Cowen & Co. Downgrades Instil Bio to Market Perform
Cowen & Co. analyst Yaron Werber downgrades Instil Bio (NASDAQ:TIL) from Outperform to Market Perform.
ON Semiconductor, Global Payments And Other Big Losers From Monday
U.S. stocks closed lower on Monday, with the Dow Jones dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session.
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
Gainers
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product candidates.
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 96 stocks hit new 52-week lows.
Why Global Payments Shares Are Trading Lower By Around 8%? Here Are 41 Stocks Moving In Monday’s Mid-Day Session
Gainers
1847 Holdings LLC (NASDAQ: EFSH) shares surged 72.7% to $3.25 after the company reported it sees over $60 million in revenue and over $7 million in cash flow from operations in 2023 from its existing portfolio.
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers
PLx Pharma (NASDAQ:PLXP) stock increased by 15.5% to $0.7 during Monday's pre-market session. The market value of their outstanding shares is at $20.3 million.
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
Gainers
Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.
Recap: Instil Bio Q2 Earnings
Instil Bio (NASDAQ:TIL) reported its Q2 earnings results on Friday, August 12, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.